medline.ch Dermatologie Tumoren Melanom

	Engineering organic, inorganic, carbon, and hybrid materials for skin cancer theragnostic: a focus on melanoma and non-melanoma. Mikrochim Acta Murugan P, Singaravel V, Manikandan C, Praburaman L, Moovendhan M, Dharmalingam K, Liu SY. PMID: 41874729 [PubMed - in process]
	Comparison between visual inspection, dermoscopy, and reflectance confocal microscopy in the diagnosis of lentigo maligna - a systematic review. Eur J Dermatol Fanton Gallo B, Fogagnolo L, Ávila Ferreira L, Cintra ML, Ingrid Amstalden EM. PMID: 41872078 [PubMed - indexed for MEDLINE]
	Sentinel Lymph Node Biopsy for Desmoplastic Melanoma: A Systematic Review and Meta-analysis. Ann Surg Oncol Yee P, Shen C, Jeun C, Mayhew M, Witt RG. PMID: 41870859 [PubMed - as supplied by publisher]
	Increased Risk of Melanoma and Basal Cell Carcinoma in Patients with Sjogren's Syndrome: A Nested Case-Control Study. Arch Dermatol Res Vaidyula VR, Lambert R, Alani O, Ungar B, Gulati N, Adalsteinsson JA. PMID: 41867668 [PubMed]
	Peripheral Blood Neutrophils and Monocytes Predict Disease Progression in Stage III Melanoma Patients Treated With Anti Programmed Cell Death Protein-1 (PD-1) Inhibitors. J Immunol Res Ventrici A, Modestino L, Cristinziano L, Caraglia F, Spatocco I, Tocchetti CG, Troiani T, Poto R, de Candia P, Varricchi G, Galdiero MR. PMID: 41866888 [PubMed - indexed for MEDLINE]
	Younger Age at Melanoma Diagnosis: A Survey Study of Indoor Tanning Use. J Am Acad Dermatol Mahoney M, Wu A, Li H, Guo D, Burbidge T, Batuyong E, Poleman S, Ernst M, Cheng T. PMID: 41864291 [PubMed - as supplied by publisher]
	Correction to: Contrasting survival outcomes and patient characteristics in 5815 patients with stage II and III melanoma: a nationwide population-based registry study from Sweden. Br J Dermatol PMID: 41863261 [PubMed - as supplied by publisher]
	The cost-effectiveness of tumour-infiltrating lymphocyte cell therapy for advanced melanoma: a systematic review. BMC Cancer Wu M, Larkin J, Furness A, Stavropoulou C. PMID: 41862835 [PubMed - as supplied by publisher]
	Spatial Lipidomics-based Melanoma Diagnostics by Integration of Mass Spectrometry Imaging and Machine Learning. J Invest Dermatol Chen YH, Liau JY, Tsai JF, Liao YH, Hsu CC. PMID: 41856467 [PubMed - as supplied by publisher]
	Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial). J Immunother Cancer Nelson A, Riise R, Alsén S, Wong A, Carlson P, Edman S, Holgersson J, Olofsson Bagge R, Johansson I, Sadik M, Edenbrandt L, Nilsson LM, Nilsson JA, Ny L. PMID: 41850738 [PubMed - indexed for MEDLINE]
	Impact of GM-CSF and two-site vaccination on clinical outcomes after multipeptide vaccination for melanoma: long-term analysis of a randomized phase II trial. Clin Cancer Res Ninmer EK, Zhu H, Sarkar A, Chianese-Bullock KA, Ross MI, Haas NB, von Mehren M, Boisvert ME, Kirkwood JM, Slingluff CL. PMID: 41849224 [PubMed - as supplied by publisher]
	Hydrogel-based delivery systems for cutaneous melanoma therapy: from chemical design and crosslinking strategies to structure-activity relationships. RSC Adv Wu Y, Zheng W, Li X, Wu S, Zhou L, Zhang D, Chen Z. PMID: 41847552 [PubMed]
	Fulminant multi-organ myositis as a rare immune-related adverse event of nivolumab-relatlimab (Opdualag) therapy in metastatic melanoma: a case report. Front Immunol Moyal A, Rosenberg E, Asale M, Peretz O, Povlaive N, Turgeman MS, Yakobson A. PMID: 41846922 [PubMed - indexed for MEDLINE]
	Hypothyroidism as Prognostic Factor in Cutaneous Melanoma: A 1553-Patient Single-Center Study. Cancer Med Klose J, Oliveira FA, Varnava C, Wiebringhaus P, Herter-Sprie GS, Schulze HJ, Hirsch T, Wellenbrock S, Kueckelhaus M. PMID: 41845929 [PubMed - indexed for MEDLINE]
	Sperm-Specific Glyceraldehyde-3-Phosphate Dehydrogenase and Energy Metabolism in Melanoma Cells. Biochemistry (Mosc) Pozdyshev DV, Medvedeva MV, Muronetz VI, Schmalhausen EV. PMID: 41843882 [PubMed - indexed for MEDLINE]
	Re: "Does tattoo exposure increase the risk of cutaneous melanoma? A population-based case-control study". Eur J Epidemiol Faheem MSB. PMID: 41843382 [PubMed - as supplied by publisher]
	Neoadjuvant systemic immunotherapy for skin cancers. Cancer Dessinioti C, Stratigos A. PMID: 41838427 [PubMed - indexed for MEDLINE]
	ASO Visual Abstract: Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients With Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial. Ann Surg Oncol Mor E, Apte S, Bressel M, Broman KK, Hieken TJ, Olofsson Bagge R, Berman RS, Lee AY, Kuijpers AM, Ollila DW, van Akkooi ACJ, Zager JS, Gyorki DE. PMID: 41838356 [PubMed - as supplied by publisher]
	Role of CTLA-4 blockade and dacarbazine therapy following anti-PD-1 resistance in melanoma. Discov Oncol Urbonas V, Dulskas A. PMID: 41838305 [PubMed - as supplied by publisher]
	Quercetin's Multifaceted Role in Alzheimer's Disease, Melanoma, and Tuberculosis: A Systematic Review with Preclinical Insights. Curr Pharm Des Pratap Swain M, Mohanty S, Gupta N, Mukherjee T, Kumar Singh S, Pattnaik A. PMID: 41837588 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 45363

Seite 1 von 2269

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung